Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

PURPOSE: S0003 was a phase III trial of carboplatin/paclitaxel with or without the hypoxic cytotoxin tirapazamine in patients with advanced or metastatic non–small-cell lung cancer (NSCLC). We investigated the relationship between clinical outcomes and plasma levels of the hypoxia-associated protein...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mack, Philip C., Redman, Mary W., Chansky, Kari, Williamson, Stephen K., Farneth, Nichole C., Lara, Primo N., Franklin, Wilbur A., Le, Quynh-Thu, Crowley, John J., Gandara, David R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2008
Schlagworte:
Tumor Biology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2653139/
https://ncbi.nlm.nih.gov/pubmed/18779603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.0662
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge